|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. IRB institutional review board IT information technology MEK mitogen-activated protein kinase 1 MIT Massachusetts Institute of Technology MMRF Multiple Myeloma Research Foundation MRF Myelin Repair Foundation NCI National Cancer Institute NHGRI National Human Genome Research Institute NIH National Institutes of Health NME new molecular entity OBQI Oncology Biomarker Qualification Initiative OSDD Open Source Drug Discovery PI3K phosphatidylinositol-3 kinase PMA premarket approval R&D research and development SEMATECH SEmiconductor MAnufacturing TECHnology START Standard Terms of Agreement for Research Trial TCGA The Cancer Genome Atlas UCSF University of California–San Francisco
|
||||||||||||||||
